FDA Asks Pharmaceutical Co. to Pull Opioid Med From Stores

FDA Asks Pharmaceutical Co. to Pull Opioid Med From Stores

News Jun 12, 2017

June 10—The Food and Drug Administration (FDA) is asking Endo Pharmaceutical to voluntarily remove its opioid pain medication, Opana ER, from the market—a decision applauded by U.S. Sen. Joe Manchin, D-W.Va.

He said in a release this marks the first time the FDA has asked a pharmaceutical company to remove a drug because of the public health consequences of abuse.

Prior to the FDA's decision, Manchin privately urged Endo Pharmaceuticals to voluntarily remove Opana from the market after the joint meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee found that the risks of the drug outweighed the benefits.

He also raised the issue directly with Commissioner Dr. Scott Gottlieb prior to his confirmation as head of the FDA.

"I am pleased to see the FDA take this unprecedented step to fight the opioid epidemic," Manchin said. "The FDA serves a critical role as the agency that oversees the approval of these addictive drugs and I have advocated for years for the FDA seek the advice of its expert advisory panel and seriously follow its recommendations concerning the approval and reevaluation of dangerously addictive drugs for public use."

He said this is a critical step, but there is more work to be done in preventing opioid addiction and in ensuring every family impacted by the epidemic has access to quality treatment facilities.

"I have seen firsthand the devastating effects prescription drug abuse have had in West Virginia and states across our nation. I will continue to do all that I can to curb this epidemic."

___ (c)2017 The Register-Herald (Beckley, W.Va.) Visit The Register-Herald (Beckley, W.Va.) at www.register-herald.com Distributed by Tribune Content Agency, LLC.

Wendy Holdren
Adapt Pharma, the Narcan manufacturer, is providing the drug to college campuses to combat the deadly opioid epidemic.
Chicago-area doctors will soon give patients Narcan along with their opioid prescriptions to prevent fatal overdoses.
First responders were commended for saving the lives of several heart attack victims, emphasizing the need for civilians to also know how to perform CPR and use an AED.
Children and young adults with Type 1 and Type 2 diabetes could be up to seven times more likely to die from sudden cardiac arrest than those who don't have diabetes.
The 'Flying Eye Hospital' features exam equipment and an operating room and travels to developing countries to treat patients with blindness or eye diseases.
Time is brain, and the Lucid System, which will eventually be tested in ambulances, could save valuable time when diagnosing and treating stroke victims.
The Pennsylvania Commission on Crime and Delinquency awarded hospital workers, first responders, and the coroner's office with a $5 million grant to purchase naloxone kits.
Paytan Fairchild donated kits containing blankets, teddy bears, and other comfort items to local hospitals, fire, and police stations to give to children who survive car accidents.
NEMSIS data helps identify disparities in who’s getting prehospital pain control.
The Arkansas Department of Health awarded 15 hospitals for providing defect-free stroke care since July of 2016.
Since Puerto Rico's major drug manufacturer was destroyed by Hurricane Maria, hospitals and pharmacies are running short on important solutions like saline and opiates.
The urgent care facility is also part of the county's reformation of its lacking mental health care system.
Freespira helps patients breathe properly to combat panic attacks and trials have shown a 64% drop in patients' emergency department costs.
Exeter Fire Department paramedics were horrified when they found 75-year-old Nancy Parker, who later died from lying in her own feces and urine for five days, neglected by her family.
Militants bombed the mosque before opening fire on the worshippers inside, blocking all exits and attacking ambulance crews arriving on scene.